David Hyman

David Hyman, CA, CBV is a highly experienced financial professional with a diverse background in finance. Currently holding positions at Rakovina Therapeutics Inc., Medicenna Therapeutics Corp., and Tandem Innovation Group Inc., David has also served as Chief Financial Officer at various other companies such as Mesentech, TheraCann International, and Merrco Payments Inc. With a Bachelor of Commerce degree in Accounting from the University of Calgary, David has gained valuable experience in financial analysis and management throughout their career.